AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower baseline reported quality of life
Number of subjects: 535
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: History of diabetes
Number of subjects: 535
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: History of gout
Number of subjects: 535
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: History of chronic obstructive pulmonary disease
Number of subjects: 535
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: Established CVD receiving guideline-recommended treatment prior to the trial
Number of subjects: 535
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: Established CVD not receiving guideline-recommended treatment prior to the trial
Number of subjects: 535
Study 28645284 — intervention group
Group type: EXPERIMENTAL
Intervention: Morbidly obese patients
Number of subjects: 535
Study 26455139 — intervention group
Group type: EXPERIMENTAL
Intervention: Clavicular hook plate combined with trapezius muscle fascia (experimental group)
Number of subjects: 66
Study 26455139 — intervention group
Group type: COMPARATOR
Intervention: Clavicular hook plate (control group)
Number of subjects: 66
Study 23689381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid-restricted (maximum fluid intake, 800 mL/d) and sodium-restricted (maximum dietary intake, 800 mg/d) diet (Intervention Group)
Number of subjects: 75
Study 23689381 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital diet with liberal fluid and sodium intake (Control Group)
Number of subjects: 75
Study 21493010 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (α2-adrenoceptor agonist, intravenous infusion)
Number of subjects: 15
Study 21493010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 19723122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonabersat 15 mg
Number of subjects: 859
Study 19723122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonabersat 40 mg
Number of subjects: 859
Study 19723122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 859
Study 18165618 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive pegfilgrastim use
Number of subjects: 852
Study 18165618 — intervention group
Group type: COMPARATOR
Intervention: Reactive pegfilgrastim use
Number of subjects: 852
Study 15548438 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened Group (SG)
Number of subjects: 9026
Study 15548438 — intervention group
Group type: COMPARATOR
Intervention: Unscreened Group (UG)
Number of subjects: 9026
Study 11898068 — intervention group
Group type: EXPERIMENTAL
Intervention: Gravity goniometer
Number of subjects: 40
Study 11898068 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictures
Number of subjects: 40
Study 11898068 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard goniometer
Number of subjects: 40
Study 10475318 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dextromethorphan 5 mg/kg before anesthetic induction (Pre group)
Number of subjects: 60
Study 10475318 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution followed by postoperative i.v. infusion of dextromethorphan 5 mg/kg (Post group)
Number of subjects: 60
Study 7605941 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (50 micrograms kg‐1 min‐1)
Number of subjects: 6
Study 7605941 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study 2220663 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and radiation therapy
Number of subjects: 80
Study 2220663 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 80
Study 364517 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐flupenthixol
Number of subjects: 38
Study 364517 — intervention group
Group type: COMPARATOR
Intervention: beta‐isomer of flupenthixol
Number of subjects: 38
Study 364517 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study 31321677 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock Wave Lithotripsy (SWL)
Number of subjects: 30
Study 28074475 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS injection (0.4 or 0.8 ng/kg)
Number of subjects: 128
Study 28074475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 24941951 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-enriched orange juice (400 mL for 21 days)
Number of subjects: 192
Study 24941951 — intervention group
Group type: COMPARATOR
Intervention: Placebo orange juice (400 mL for 21 days)
Number of subjects: 192
Study 24941951 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber-enriched orange juice
Number of subjects: 192
Study 24941951 — intervention group
Group type: COMPARATOR
Intervention: Both groups (fiber and placebo)
Number of subjects: 192
Study 23053707 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive nonsurgical technique (MINST)
Number of subjects: 29
Study 23053707 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical technique (MIST)
Number of subjects: 29
Study 21663648 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 g milk fat/d from test butter and cheese with 0.24 wt% phytanic acid
Number of subjects: 14
Study 21663648 — intervention group
Group type: COMPARATOR
Intervention: Control diet with 0.13 wt% phytanic acid
Number of subjects: 14
Study 19562886 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 25
Study 19562886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 16728452 — intervention group
Group type: EXPERIMENTAL
Intervention: Gly16
Number of subjects: 31
Study 16728452 — intervention group
Group type: COMPARATOR
Intervention: Arg16
Number of subjects: 31
Study 14702229 — intervention group
Group type: EXPERIMENTAL
Intervention: four‐session cognitive‐behavioural intervention starting 5‐10 weeks after the injury
Number of subjects: 152
Study 14702229 — intervention group
Group type: COMPARATOR
Intervention: no intervention
Number of subjects: 152
Study 11978924 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT)
Number of subjects: 17
Study 11978924 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutter device
Number of subjects: 17
Study 11477826 — intervention group
Group type: EXPERIMENTAL
Intervention: Radix Codonopsitis Pilosulae
Number of subjects: 103
Study 11477826 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 103
Study 11477826 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-HQD type)
Number of subjects: 103
Study 9098299 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure patching
Number of subjects: 201
Study 9098299 — intervention group
Group type: COMPARATOR
Intervention: No patching
Number of subjects: 201
Study 2693116 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual salbutamol tablet 2 mg (SL)
Number of subjects: 7
Study 2693116 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallowed tablet 2 mg (O)
Number of subjects: 7
Study 2693116 — intervention group
Group type: EXPERIMENTAL
Intervention: Metered dose inhaler 200 micrograms (MDI)
Number of subjects: 7
Study 2693116 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 7
Study 370171 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (smoking cessation advice)
Number of subjects: 1445
Study 370171 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1445
Study 31685429 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1 (G1)
Number of subjects: 90
Study 31685429 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 2 (G2)
Number of subjects: 90
Study 31685429 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 90
Study 31350952 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care using Eye Movement Desensitization and Reprocessing (EMDR) technique, 2 sessions (total of 60 sessions), each lasting 45 to 60 minutes.
Number of subjects: 60
Study 31350952 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 60
Study 30078537 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 1.0%–ketorolac 0.3% injection
Number of subjects: 25
Study 30078537 — intervention group
Group type: COMPARATOR
Intervention: Basic saline solution (Control)
Number of subjects: 25
Study 26292645 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic oxygen therapy (10 L/min for 3 months)
Number of subjects: 102
Study 26292645 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 mg daily for 3 months)
Number of subjects: 102
Study 26292645 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 3 months)
Number of subjects: 102
Study 24356636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense weekly paclitaxel and carboplatin (dd-TC)
Number of subjects: 637
Study 24356636 — intervention group
Group type: COMPARATOR
Intervention: Conventional tri-weekly paclitaxel and carboplatin (c-TC)
Number of subjects: 637
Study 22629129 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia (Anesthesia Group, AG)
Number of subjects: 40
Study 22629129 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not anesthetized patients)
Number of subjects: 40
Study 20080382 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 500 mg, Caffeine 50 mg, Opium 25 mg
Number of subjects: 232
Study 20080382 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 500 mg, Caffeine 50 mg, Opium 50 mg
Number of subjects: 232
Study 20080382 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 100 mg
Number of subjects: 232
Study 20080382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 17396618 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranlukast 450 mg daily
Number of subjects: 41
Study 17396618 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone 200 microg daily
Number of subjects: 41
Study 15378234 — intervention group
Group type: EXPERIMENTAL
Intervention: Permacol injection
Number of subjects: 50
Study 15378234 — intervention group
Group type: COMPARATOR
Intervention: Macroplastique injection
Number of subjects: 50
Study 12244504 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSheath group (disposable sheath system)
Number of subjects: 226
Study 12244504 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope group (conventional video colonoscope)
Number of subjects: 226
Study 10710824 — intervention group
Group type: EXPERIMENTAL
Intervention: New microemulsion formulation of cyclosporine
Number of subjects: 18
Study 10710824 — intervention group
Group type: COMPARATOR
Intervention: Marketed formulation of cyclosporine
Number of subjects: 18
Study 7725883 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh tourniquet inflated after exanguination of the leg not being operated on
Number of subjects: 40
Study 7725883 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tourniquet)
Number of subjects: 40
Study 1838749 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC‐7251 1% cream
Number of subjects: 28
Study 1838749 — intervention group
Group type: COMPARATOR
Intervention: Cream base
Number of subjects: 28
Study 7015173 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin (LDH) injected subcutaneously in the contralateral thigh
Number of subjects: 0
Study 7015173 — intervention group
Group type: COMPARATOR
Intervention: Low-dose heparin (LDH) injected subcutaneously in the contralateral abdominal skin-fold
Number of subjects: 0
Study 29979275 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 set of 3 bounce drop jumps (BDJs) with 4 minutes recovery
Number of subjects: 29
Study 29979275 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 set of 3 bounce drop jumps (BDJs) with 12 minutes recovery
Number of subjects: 29
Study 29979275 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 set of 3 bounce drop jumps (BDJs) with 15 seconds recovery
Number of subjects: 29
Study 31449568 — intervention group
Group type: COMPARATOR
Intervention: Suspended lunge
Number of subjects: 20
Study 31449568 — intervention group
Group type: COMPARATOR
Intervention: Bulgarian squat
Number of subjects: 20
Study 31449568 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspended lunge-BOSU
Number of subjects: 20
Study 28217880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (CRT) and treatment as usual (TAU)
Number of subjects: 48
Study 28217880 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 48
Study 28217880 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy (CRT)
Number of subjects: 48
Study 27290988 — intervention group
Group type: COMPARATOR
Intervention: Voluven (saline-based 6% hydroxyethyl starch 130/0.4)
Number of subjects: 40
Study 27290988 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetraspan (balanced 6% hydroxyethyl starch 130/0.4)
Number of subjects: 40
Study 27290988 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Voluven and Tetraspan)
Number of subjects: 40
Study 24524414 — intervention group
Group type: EXPERIMENTAL
Intervention: Ponto Pro
Number of subjects: 14
Study 24524414 — intervention group
Group type: EXPERIMENTAL
Intervention: BP100
Number of subjects: 14
Study 24524414 — intervention group
Group type: COMPARATOR
Intervention: Previous bone‐anchored hearing aids
Number of subjects: 14
Study 22236064 — intervention group
Group type: EXPERIMENTAL
Intervention: Montessori-based activities conducted by family carers
Number of subjects: 0
Study 22236064 — intervention group
Group type: COMPARATOR
Intervention: Control waiting list condition
Number of subjects: 0
Study 19409578 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 68
Study 19409578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 19409578 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low energy diet (600-800 kcal/d)
Number of subjects: 68
Study 19409578 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of both groups (Orlistat and Placebo)
Number of subjects: 68
Study 17974365 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (UNIMMAP)
Number of subjects: 2550
Study 17974365 — intervention group
Group type: COMPARATOR
Intervention: Iron/Folic Acid
Number of subjects: 2550
Study 16271571 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography for diagnosing congenital muscular torticollis (CMT)
Number of subjects: 1021
Study 16271571 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive logistic regression model incorporating clinical correlates
Number of subjects: 1021
Study 12549689 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure system
Number of subjects: 112
Study 12549689 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 112
Study 9457811 — intervention group
Group type: EXPERIMENTAL
Intervention: brachytherapy + hyperthermia (HT)
Number of subjects: 112
Study 9457811 — intervention group
Group type: COMPARATOR
Intervention: brachytherapy (no heat)
Number of subjects: 112
Study 7883848 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg iodine
Number of subjects: 117
Study 7883848 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg iodine
Number of subjects: 117
Study 7883848 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg iodine
Number of subjects: 117
Study 1453217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin protein at 0.8 g/(kg.d)
Number of subjects: 0
Study 1453217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin protein at 0.6 g/(kg.d)
Number of subjects: 0
Study 1453217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin protein at 0.4 g/(kg.d)
Number of subjects: 0
Study 1453217 — intervention group
Group type: COMPARATOR
Intervention: Egg protein at 0.6 g/(kg.d)
Number of subjects: 0
Study 1453217 — intervention group
Group type: COMPARATOR
Intervention: Egg protein at 0.45 g/(kg.d)
Number of subjects: 0
Study 1453217 — intervention group
Group type: COMPARATOR
Intervention: Egg protein at 0.3 g/(kg.d)
Number of subjects: 0
Study 6366810 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethopyrazine (200 mg)/trimethoprim (250 mg) combination
Number of subjects: 72
Study 6366810 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (400 mg sulphamethoxazole plus 80 mg trimethoprim)
Number of subjects: 72
Study 31375444 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateralised tibial jig placement
Number of subjects: 216
Study 31375444 — intervention group
Group type: COMPARATOR
Intervention: Control group (mid-point of tibial plateau as reference)
Number of subjects: 216
Study 30543642 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilemma-focused intervention (DFI)
Number of subjects: 128
Study 30543642 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 128
Study 30543642 — intervention group
Group type: COMPARATOR
Intervention: CBT group + CBT individual
Number of subjects: 128
Study 30543642 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT group + DFI individual
Number of subjects: 128
Study 26912543 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (45/15, 60/30, or 90/30 mg daily as tolerated)
Number of subjects: 1445
Study 26912543 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 1445
Study 26912543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1445
Study 25804839 — intervention group
Group type: EXPERIMENTAL
Intervention: R-MCP (rituximab plus mitoxantrone, chlorambucil, and prednisolone)
Number of subjects: 129
Study 25804839 — intervention group
Group type: COMPARATOR
Intervention: MCP (mitoxantrone, chlorambucil, and prednisolone)
Number of subjects: 129
Study 25804839 — intervention group
Group type: EXPERIMENTAL
Intervention: R-MCP
Number of subjects: 129
Study 25804839 — intervention group
Group type: COMPARATOR
Intervention: MCP
Number of subjects: 129
Study 23601497 — intervention group
Group type: EXPERIMENTAL
Intervention: Succimer
Number of subjects: 0
Study 23601497 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 20646510 — intervention group
Group type: EXPERIMENTAL
Intervention: TRAE + cryoablation
Number of subjects: 77
Study 20646510 — intervention group
Group type: COMPARATOR
Intervention: TRAE
Number of subjects: 77
Study 17959591 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS at the PC-5 and PC-6 points
Number of subjects: 36
Study 17959591 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS at non-acupoints of both shoulders
Number of subjects: 36
Study 17959591 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 36
Study 17022381 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 50
Study 17022381 — intervention group
Group type: COMPARATOR
Intervention: Conventional stent implantation
Number of subjects: 50
Study 14617323 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of calcium-gluconate at a dose of 1.8 mmol calcium per hour
Number of subjects: 50
Study 14617323 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous IV infusion of calcium-gluconate
Number of subjects: 50
Study 14617323 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study 14617323 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-gluconate
Number of subjects: 50
Study 11232756 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor metabolic control (26 patients)
Number of subjects: 44
Study 11232756 — intervention group
Group type: COMPARATOR
Intervention: Well-controlled diabetic patients (18 patients)
Number of subjects: 44
Study 11232756 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (12 subjects)
Number of subjects: 44
Study 9213104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based neoadjuvant chemotherapy plus radiotherapy
Number of subjects: 161
Study 9213104 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 161
Study 9213104 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical nodal necrosis
Number of subjects: 161
Study 8322240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 20 cm H2O, PEEP 0 cm H2O
Number of subjects: 9
Study 8322240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 20 cm H2O, PEEP 5 cm H2O
Number of subjects: 9
Study 8322240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 10 cm H2O, PEEP 0 cm H2O
Number of subjects: 9
Study 8322240 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with PIP 10 cm H2O, PEEP 5 cm H2O
Number of subjects: 9
Study 8322240 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of PEEP to both levels of PIP
Number of subjects: 9
Study 3114302 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (BCT; 3.75 mg/day; n = 14)
Number of subjects: 28
Study 3114302 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 14)
Number of subjects: 28
Study 31565955 — intervention group
Group type: EXPERIMENTAL
Intervention: Project ImPACT for Toddlers
Number of subjects: 25
Study 31565955 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 25
Study 29172949 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic liver resection (LLR)
Number of subjects: 50
Study 29172949 — intervention group
Group type: COMPARATOR
Intervention: Open liver resection (OLR)
Number of subjects: 50
Study 26897592 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain assessment and management algorithms (ALGs) with intensive training and support.
Number of subjects: 485
Study 26897592 — intervention group
Group type: COMPARATOR
Intervention: Pain education (EDU) only.
Number of subjects: 485
Study 25315205 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (nurse case-manager-based model)
Number of subjects: 476
Study 25315205 — intervention group
Group type: COMPARATOR
Intervention: Usual care control (nonscreened patients)
Number of subjects: 476
Study 23019944 — intervention group
Group type: EXPERIMENTAL
Intervention: Maixuekang Capsule (MC), 12 capsules daily for 12 months
Number of subjects: 236
Study 23019944 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (RTT)
Number of subjects: 236